Dr. Mary Barbera explores the latest in autism research, focusing on Dr. Karen Parker's study on intranasal vasopressin. Despite challenges, such as translating animal model research to human application, vasopressin shows promise in improving social behavior and reducing anxiety in children with autism. Supported by the Simons Foundation, this research highlights potential breakthroughs in autism treatment. Join the movement through initiatives like the SPARK program, fostering collaboration and hope for a brighter future in autism care.